healthcare communications

Kimaya Dixit's picture

FDA Opens Up Social Media to Pharma Companies with New Guidelines


When it comes to social media in the pharma [[wysiwyg_imageupload:174:]]
space, PR and communications professionals have fought a very long and laborious battle. Fortunately, the U.S. Food and Drug Administration (FDA) has finally come through with new and officially issued guidance for pharma's interactive marketing activities online. While this certainly clarity to an otherwise dark and restrictive social media-pharma terrain, there are a few bumps along the way to keep in mind.

First and foremost, there is no denying that the somewhat unrestricted freedom to tweet, post, blog, pin, etc. is right in line with where the future of real-time reporting and health PR is headed. These guidelines will most likely lead to real-time interactive marketing initiatives quickly slipping into PR strategies for pharma companies, both big and small. Read full post »

Tim Weinheimer's picture

Top Three Tips for Meeting FDA’s New Interactive Promotional Media Guidelines


With the FDA release of its latest guidelines on[[wysiwyg_imageupload:170:]]
the use of new interactive promotional media there are new opportunities for PR professionals. The FDA’s new report is titled “Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics” and within the report there are 3 opportunities for PR professionals related to managing online influencer relationships and FDA-approved content optimization.

The Top 3 Tips:

“Representatives” or agencies can squarely sharpen their communications outreach in 2014 in response to these new guidelines by taking the following steps to digitally optimize their clients’ campaigns for success.


1.    Subscribe to influencer database tools and software. Read full post »

Maria Sherstneva's picture

Healthcare Communications in Russia


Every PR specialist who starts working in[[wysiwyg_imageupload:169:]]
healthcare communications knows that it is on the one hand a great responsibility to promote something that saves people’s lives and really makes a difference in the world but on the other hand is a great challenge. Many medical topics are difficult to pitch and to have discussed in the media.  In addition, the area is highly regulated not only by governmental institutions but also by the clients themselves.  Under the auspices of Ketchum’s Global Scholar program, I recently had the opportunity to travel from Moscow to Ketchum’s New York office with a view to exchange our healthcare expertise, knowledge and insights.

Having a basic idea of the U.S. healthcare system already gave me an understanding of the dramatic differences between our countries. But I could not believe it influenced the approach to communications so much. Learning about the extent of FDA oversight in the U.S.I saw that there were far more distinct boundaries to work within. Read full post »

Christa Lombardi's picture

Hit 90 Seconds of Uninhibited Creativity


Last month, I threw out all inhibitions and
hit fast forward 90 years into the [[wysiwyg_imageupload:165:]]future.

Recently, as we celebrated Ketchum's 90th anniversary, agency CEO Rob Flaherty shared that 10 percent of the focus for the occasion would be on the past, and 90 percent would be on the future. With that, I sat around a conference room table with four colleagues – all from different specialty areas – tasked with sharing our vision for the next 90 years with the New York office. Read full post »

In: Creativity  /   filed under: creativity | healthcare communications
Nancy Hicks's picture

Creativity In Healthcare


This article first appeared on For more thought leadership on creativity, please visit  

The title seems oxymoronic, yet creativity can
live in the regulated land of [[wysiwyg_imageupload:164:]]healthcare. The challenges are significant and inherent in the culture of the industry.

FDA regulation puts many restrictions on what you can say about healthcare products. Off-label claims, or claims of efficacy prior to approval are forbidden and communicators traverse this landscape with the caution of an explorer avoiding grenades in unfriendly territory. Both pharma and device companies have incurred fines or worse from the government for marketing offenses in this arena. Read full post »

In: Creativity  /   filed under: creativity | healthcare communications